1.
GENDER-BASED ANALYSIS OF ADVERSE EFFECTS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES: A COMPARATIVE . GSR [Internet]. 2025 Mar. 26 [cited 2026 Nov. 16];2(1):418-22. Available from: https://global-science-review.com/ojs/index.php/gsr/article/view/238